Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course versus long-course prophylactic antibiotics after caesarean section
PACTR202608750810511Not yet recruiting
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ceftriaxone, metronidazole and cefuroxime in surgical site infection (SSI) (2 arms). Primary endpoint: Incidence of postoperative infections. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
ceftriaxonemetronidazolecefuroxime
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on PACTR202608750810511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202608750810511.